Showing results (731-740 of 1,169) with videos related to

Sort By:
Pageof 117
Annals of Surgical Oncology|July 19, 2012
Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCCYong Yi, Han Wu, Qiang Gao, et al.
Molecular Cancer|August 2, 2024
Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblastsDe-Zhen Guo, Xin Zhang, Sen-Quan Zhang, et al.
Innovation (Cambridge (Mass.))|May 3, 2024
Integrated proteomic profiling identifies amino acids selectively cytotoxic to pancreatic cancer cellsAlfred Akinlalu, Zachariah Flaten, Komila Rasuleva, et al.
Molecular Cancer|May 21, 2020
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Surgical Endoscopy|August 5, 2020
Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approachXiu-Tao Fu, Zheng Tang, Jia-Feng Chen, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|October 1, 2019
Laparoscopic Versus Open Left Lateral Segmentectomy for Large Hepatocellular Carcinoma: A Propensity Score-Matched AnalysisXiu-Tao Fu, Zheng Tang, Ying-Hong Shi, et al.
Hepatobiliary Surgery and Nutrition|August 26, 2022
Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosisYuanfei Peng, Zheng Wang, Xudong Qu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoringChang Liu, Zhen Zhao, Jia Fan, et al.
BMJ Oncology|March 6, 2025
Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysisHui-Chuan Sun, Xiao-Dong Zhu, Zi-Yi Wang, et al.
Carcinogenesis|July 27, 2021
CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expressionMin-Cheng Yu, Guang-Yu Ding, Peng Ma, et al.
Pageof 117